{"id":"https://openalex.org/W2096043422","doi":"https://doi.org/10.1038/sj.bjc.6690142","title":"Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer","display_name":"Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer","publication_year":1999,"publication_date":"1999-01-29","ids":{"openalex":"https://openalex.org/W2096043422","doi":"https://doi.org/10.1038/sj.bjc.6690142","mag":"2096043422","pmid":"https://pubmed.ncbi.nlm.nih.gov/10070886","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2362687"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6690142","doi":"https://doi.org/10.1038/sj.bjc.6690142","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6690142","pdf_url":"https://www.nature.com/articles/6690142.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6690142.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108337708","display_name":"John A. Foekens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J A Foekens","raw_affiliation_strings":["Department of Medical Oncology, Mount Sinai Hospital, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mount Sinai Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1291836623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084226800","display_name":"Eleftherios P. Diamandis","orcid":"https://orcid.org/0000-0002-1589-820X","observed_orcids":["https://orcid.org/0000-0002-1589-820X","https://orcid.org/0009-0000-8901-2072"]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"E P Diamandis","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, Canada and Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, Toronto, Ontario, University of Toronto, Ontario, Canada","Department of Pathology and Laboratory Medicine, Canada and Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, Toronto, Ontario, University of Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Canada and Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, Toronto, Ontario, University of Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I185261750"]},{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Canada and Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, Toronto, Ontario, University of Toronto, Canada","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022074201","display_name":"He Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"H Yu","raw_affiliation_strings":["Department of Laboratory Medicine and Pathobiology , University of Toronto , Ontario , Canada; Diagnostic Systems Laboratories , Webster , Texas , USA;","Kefkens Institute , Dr Molewaterplein 50 , 3015 GE Rotterdam , The Netherlands","Diagnostic Systems Laboratories, Webster, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine and Pathobiology , University of Toronto , Ontario , Canada; Diagnostic Systems Laboratories , Webster , Texas , USA;","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Kefkens Institute , Dr Molewaterplein 50 , 3015 GE Rotterdam , The Netherlands","institution_ids":[]},{"raw_affiliation_string":"Diagnostic Systems Laboratories, Webster, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109184681","display_name":"M P Look","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M P Look","raw_affiliation_strings":["Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Ontario, Canada","Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1291836623"]},{"raw_affiliation_string":"Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005328653","display_name":"Marion E. Meijer\u2010van Gelder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M E Meijer-van Gelder","raw_affiliation_strings":["Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Ontario, Canada","Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1291836623"]},{"raw_affiliation_string":"Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108418848","display_name":"Wim L.J. van Putten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267036","display_name":"Academisch Ziekenhuis Rotterdam","ror":"https://ror.org/00xtwy257","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4405267036"]},{"id":"https://openalex.org/I4405267285","display_name":"Daniel den Hoed Kliniek","ror":"https://ror.org/020rz5h24","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908","https://openalex.org/I4405267285"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W L J van Putten","raw_affiliation_strings":["Department of Statistics, Rotterdam Cancer Institute (Daniel den Hoed Kliniek), Academic Hospital Rotterdam, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Statistics, Rotterdam Cancer Institute (Daniel den Hoed Kliniek), Academic Hospital Rotterdam, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4405267036","https://openalex.org/I4405267285"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113498321","display_name":"Jan G. M. Klijn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J G M Klijn","raw_affiliation_strings":["Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Ontario, Canada","Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I1291836623"]},{"raw_affiliation_string":"Division of Endocrine Oncology (Department of Medical Oncology), Mount Sinai Hospital, Toronto, Canada","institution_ids":["https://openalex.org/I1291836623"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":2.2655,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.88474576,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"79","issue":"5-6","first_page":"888","last_page":"894"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":1.0},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7390000224113464},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.953000009059906},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.8830000162124634},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7490000128746033},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.675000011920929},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7770000100135803},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7919999957084656},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.37599998712539673}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7956672310829163},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.7752786874771118},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7357762455940247},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7086496353149414},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6542676687240601},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.5494725108146667},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.4920734763145447},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.48718494176864624},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47760674357414246},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.41855719685554504}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D017697","descriptor_name":"Premenopause","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017698","descriptor_name":"Postmenopause","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1038/sj.bjc.6690142","doi":"https://doi.org/10.1038/sj.bjc.6690142","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6690142","pdf_url":"https://www.nature.com/articles/6690142.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2362687","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2362687","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:10070886","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10070886","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/60fc6e8c-a800-4691-a0c7-1aa912f9beb3","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/60fc6e8c-a800-4691-a0c7-1aa912f9beb3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Foekens, J, Diamandis, EP, Yu, H, Look, M, Meijer - Gelder, M, Putten, W & Klijn, J 1999, 'Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer', British Journal of Cancer, vol. 79, no. 5/6, pp. 888-894. https://doi.org/10.1038/sj.bjc.6690142","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/60fc6e8c-a800-4691-a0c7-1aa912f9beb3","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/60fc6e8c-a800-4691-a0c7-1aa912f9beb3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Cancer, 79(5/6), 888 - 894. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6690142","doi":"https://doi.org/10.1038/sj.bjc.6690142","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6690142","pdf_url":"https://www.nature.com/articles/6690142.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2096043422.pdf","grobid_xml":"https://content.openalex.org/works/W2096043422.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W23122061","https://openalex.org/W1531559622","https://openalex.org/W1537206836","https://openalex.org/W1558913702","https://openalex.org/W1570640139","https://openalex.org/W1581268753","https://openalex.org/W1648484638","https://openalex.org/W1937480514","https://openalex.org/W1949259756","https://openalex.org/W1963923695","https://openalex.org/W1966442692","https://openalex.org/W1979300931","https://openalex.org/W1979496966","https://openalex.org/W1984533079","https://openalex.org/W1986819031","https://openalex.org/W1991962266","https://openalex.org/W1997492763","https://openalex.org/W1999920704","https://openalex.org/W2005113904","https://openalex.org/W2007657701","https://openalex.org/W2017827421","https://openalex.org/W2023843856","https://openalex.org/W2024338659","https://openalex.org/W2027066393","https://openalex.org/W2030587002","https://openalex.org/W2031720517","https://openalex.org/W2055573496","https://openalex.org/W2058041963","https://openalex.org/W2067772772","https://openalex.org/W2070284356","https://openalex.org/W2076667824","https://openalex.org/W2077000148","https://openalex.org/W2080081195","https://openalex.org/W2087376487","https://openalex.org/W2089335503","https://openalex.org/W2091759497","https://openalex.org/W2097596862","https://openalex.org/W2127767016","https://openalex.org/W2128741716","https://openalex.org/W2152776758","https://openalex.org/W2169354513","https://openalex.org/W2196919854","https://openalex.org/W2235954515","https://openalex.org/W2323421875","https://openalex.org/W2330292521","https://openalex.org/W2335679869","https://openalex.org/W2396491869","https://openalex.org/W2405442768","https://openalex.org/W3041047318","https://openalex.org/W4205307388"],"related_works":["https://openalex.org/W1537206836","https://openalex.org/W1966442692","https://openalex.org/W7216748527","https://openalex.org/W2080081195","https://openalex.org/W51470044","https://openalex.org/W2264076879","https://openalex.org/W2411102452","https://openalex.org/W2104730114","https://openalex.org/W7097472211","https://openalex.org/W2474807508"],"abstract_inverted_index":{"Prostate-specific":[0],"antigen":[1],"(PSA)":[2],"is":[3,247],"a":[4,10,13,160,183,192,199,262],"serine":[5],"protease":[6],"which":[7],"may":[8,270],"play":[9],"role":[11],"in":[12,32,41,51,63,72,86,107,117,254],"variety":[14],"of":[15,30,95,111,130,134,139,157,163,186,207,231,243,252,256],"cancer":[16,78,267],"types,":[17],"including":[18],"breast":[19,33,43,64,77,147,181,258,266],"cancer.":[20],"In":[21,143,177,212],"the":[22,28,93,128,137,155,250],"present":[23],"study,":[24],"we":[25],"evaluated":[26],"whether":[27],"level":[29,185,251],"PSA":[31,54,96,131,149,164,187,238,253],"tumour":[34,65],"cytosol":[35],"could":[36,169],"be":[37,170,261],"associated":[38],"with":[39,46,70,75,80,89,97,132,145,165,179],"prognosis":[40,71],"primary":[42,76,146,257],"cancer,":[44,148,182],"or":[45,136],"response":[47,81,194,217],"to":[48,82,154,172,175,191,195,218,264],"tamoxifen":[49,84,196,274],"therapy":[50,85,219],"recurrent":[52,90,180,210],"disease.":[53,91,211],"levels":[55,94,102,129],"were":[56,68,103],"determined":[57],"by":[58],"enzyme-linked":[59],"immunosorbent":[60],"assay":[61],"(ELISA)":[62],"cytosols,":[66],"and":[67,79,113,116,159,198,202,220,233],"correlated":[69],"1516":[73],"patients":[74,88,144,178,268],"first-line":[83],"434":[87],"Relating":[92],"classical":[98],"prognostic":[99],"factors,":[100],"low":[101],"more":[104],"often":[105],"found":[106],"larger":[108],"tumours,":[109],"tumours":[110,259],"older":[112],"post-menopausal":[114],"patients,":[115],"steroid":[118,234],"hormone":[119,235],"receptor-negative":[120],"tumours.":[121],"There":[122],"was":[123,150,188,239],"no":[124],"significant":[125],"association":[126,162],"between":[127],"grade":[133],"differentiation":[135],"number":[138],"involved":[140],"lymph":[141],"nodes.":[142],"not":[151],"significantly":[152,189],"related":[153,190],"rate":[156],"relapse,":[158],"positive":[161],"an":[166,240],"improved":[167],"survival":[168,204],"attributed":[171],"its":[173],"relationship":[174],"age.":[176],"high":[184],"poor":[193,244],"therapy,":[197],"short":[200],"progression-free":[201],"overall":[203],"after":[205],"start":[206],"treatment":[208],"for":[209,216,221,225],"Cox":[213],"multivariate":[214],"analyses":[215],"(progression-free)":[222],"survival,":[223],"corrected":[224],"age/menopausal":[226],"status,":[227,237],"disease-free":[228],"interval,":[229],"site":[230],"relapse":[232],"receptor":[236],"independent":[241],"variable":[242],"prognosis.":[245],"It":[246],"concluded":[248],"that":[249],"cytosols":[255],"might":[260],"marker":[263],"select":[265],"who":[269],"benefit":[271],"from":[272],"systemic":[273],"therapy.":[275]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}